DC Vaccination for Postremission Therapy in AML
Clinical trial NCT01734304 · COMPLETED
Trial details
- NCT number
- NCT01734304
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-05
- Primary completion
- 2018-03-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.